The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...
Celebrities have been striving for health in 2025, with many dropping significant amounts of weight — in many cases with the help of GLP-1 medications like Ozempic. Below are four A-list stars who ...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...
Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. My Instagram algorithm has decided that I am a woman, and, therefore, I must want to ...
The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...
California will end Medi-Cal coverage for popular weight-loss drugs like Wegovy starting Jan. 1, citing soaring pharmaceutical costs. Low-income residents losing coverage will be advised to rely on ...
LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...
LONDON, Dec 9 (Reuters) - Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results